TVM Life Science Innovation II SCSP
TVM Life Science · adviser of record: TVM Life Science Management, Inc. · 2018 vintage
TVM Life Science Innovation II SCSP is a 2018 venture fund managed by TVM Life Science, with $369mm raised (Form D, amount sold). It reported $430mm in gross assets at year-end 2025, 1.17x its size, its highest reported value.
- Latest value held
- $430mm year-end 2025
- Peak
- $430mm year-end 2025
- Fund size
- $369mm Form D, amount sold
- Held vs. size
- 1.17x peak 1.17x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $430mm | 1.17x | +80% over 2 yrs |
| 2023 | $239mm | 0.65x | +57% |
| 2022 | $153mm | 0.41x | +40% |
| 2021 | $109mm | 0.30x | +131% |
| 2020 | $47.3mm | 0.13x | -87% |
| 2019 | $377mm | 1.02x | +186594% |
| 2018 | $202k | 0.00x | – |
Other funds from TVM Life Science
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-4015456079. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.